Health and Healthcare
GlaxoSmithKline Continues Down A Dangerous Path
Published:
Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks.
According to The Wall Street Journal "the Food and Drug Administration is considering whether Avandia’s use should be restricted." Studies show that the drug can increase risk of heart attack. In a research paper form Wake Forest University doctors found that patients taking Avandia had a 42% greater chance of having a heart attack than those in the control group.
The whole incident begs that question of what major drug companies never take their own products off the market when there is overwhelming evidence that they create health risk. There must be some actuary who works out the balance between profit and potential liability if court cases for wrongful death begin to emerge.
Of course, that leaves out the question of ethics.
Douglas A. McIntyre
Robinhood revolutionized commission free investing, and it continues to do so today. With a few simple taps you can trade stocks like Nvidia and Amazon, market beating mutual funds, and trade options with Robinhood Financial. FDIC insurance coverage is just another benefit.
And, you can buy and sell cryptocurrencies like Bitcoin (BTC), Ethereum (ETH), and Dogecoin (DOGE) with Robinhood Crypto.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.